Clinical trial
A Multi-center, Prospective, Open-label, Controlled Study of the Pharmacokinetics and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injuries
NCT05171673 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Prospective, Open-label, Controlled Study of the Pharmacokinetics and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injuries
- Lead sponsor
- IBSA Institut Biochimique SA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2021
- Completion date
- July 12, 2024
- Enrollment
- 151 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.